Revolution Medicines (RVMD) Enterprise Value (2018 - 2025)
Historic Enterprise Value for Revolution Medicines (RVMD) over the last 8 years, with Q3 2025 value amounting to -$1.9 billion.
- Revolution Medicines' Enterprise Value fell 2465.52% to -$1.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.9 billion, marking a year-over-year decrease of 2465.52%. This contributed to the annual value of -$2.3 billion for FY2024, which is 2354.85% down from last year.
- According to the latest figures from Q3 2025, Revolution Medicines' Enterprise Value is -$1.9 billion, which was down 2465.52% from -$2.1 billion recorded in Q2 2025.
- Over the past 5 years, Revolution Medicines' Enterprise Value peaked at -$461.4 million during Q2 2022, and registered a low of -$2.3 billion during Q4 2024.
- Its 5-year average for Enterprise Value is -$1.2 billion, with a median of -$909.5 million in 2023.
- As far as peak fluctuations go, Revolution Medicines' Enterprise Value surged by 2860.63% in 2022, and later plummeted by 18730.52% in 2023.
- Revolution Medicines' Enterprise Value (Quarter) stood at -$577.1 million in 2021, then decreased by 11.76% to -$644.9 million in 2022, then tumbled by 187.31% to -$1.9 billion in 2023, then fell by 23.55% to -$2.3 billion in 2024, then grew by 15.63% to -$1.9 billion in 2025.
- Its Enterprise Value stands at -$1.9 billion for Q3 2025, versus -$2.1 billion for Q2 2025 and -$2.1 billion for Q1 2025.